Giant Biogene Holding Co., Ltd. (HKG:2367)

Giant Biogene Holding Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	41,016	50,360	34,746	32,794	-	-
Market Cap Growth	-18.88%	44.94%	5.95%	-	-	-
Enterprise Value	31,326	43,851	31,750	31,531	-	-
Last Close Price	38.30	48.78	34.09	32.18	-	-
PE Ratio	15.73	22.95	21.73	41.68	-	-
Forward PE	14.18	19.66	19.71	-	-	-
PS Ratio	6.13	8.54	8.95	12.27	-	-
PB Ratio	4.07	6.65	7.22	10.23	-	-
P/TBV Ratio	4.08	6.66	7.24	10.26	-	-
P/FCF Ratio	25.40	26.37	22.19	37.24	-	-
P/OCF Ratio	20.41	23.18	19.14	31.14	-	-
EV/Sales Ratio	4.68	7.44	8.18	11.80	-	-
EV/EBITDA Ratio	10.92	17.72	17.54	24.07	-	-
EV/EBIT Ratio	11.20	18.06	17.88	24.61	-	-
EV/FCF Ratio	19.40	22.96	20.28	35.80	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	-	-
Debt / EBITDA Ratio	0.00	0.00	0.00	0.00	-	-
Debt / FCF Ratio	0.01	0.00	0.00	0.00	-	-
Asset Turnover	0.64	0.85	0.87	0.43	0.30	0.54
Inventory Turnover	2.88	3.88	3.00	2.70	2.57	3.18
Quick Ratio	4.60	7.21	7.36	8.16	1.07	1.02
Current Ratio	4.87	7.66	7.79	9.03	1.09	1.05
Return on Equity (ROE)	29.86%	35.88%	40.18%	51.98%	112.30%	102.70%
Return on Assets (ROA)	16.75%	21.92%	24.84%	12.86%	10.81%	22.61%
Return on Capital (ROIC)	21.05%	24.80%	27.93%	36.73%	77.18%	62.50%
Return on Capital Employed (ROCE)	27.60%	31.70%	36.30%	39.70%	88.00%	168.60%
Earnings Yield	6.04%	4.36%	4.60%	3.45%	-	-
FCF Yield	3.94%	3.79%	4.51%	2.69%	-	-
Dividend Yield	3.41%	1.31%	1.42%	-	-	-
Payout Ratio	40.17%	44.05%	-	36.67%	307.92%	-
Buyback Yield / Dilution	-3.40%	-1.93%	3.77%	-2.03%	-0.09%	-
Total Shareholder Return	0.05%	-0.62%	5.19%	-2.03%	-0.09%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.